← FDA Drug Approvals (Drugs@FDA)

NABUMETONE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: SCIEGEN PHARMS · Approved 2008-09-24

Drug application

FDA Application #

ANDA078420

Application type

Abbreviated New Drug Application (Generic)

Brand name

NABUMETONE

Generic name

NABUMETONE

Active ingredients

NABUMETONE

Dosage form

TABLET

Route

ORAL

Marketing status

Prescription

Sponsor

SCIEGEN PHARMS

Manufacturer

ScieGen Pharmaceuticals Inc

First approval

2008-09-24

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown